Home zacks
 

Keywords :   


Tag: zacks

Texas Instruments Incorporated (TXN) Rating Increased to Hold at Zacks Investment Research

2016-03-25 14:59:49| Semiconductors - Topix.net

According to Zacks, "Texas Instruments is one of the largest suppliers of analog integrated circuits. Fourth-quarter earnings beat the Zacks Consensus Estimate .Though the communications, personal electronics and other markets were weak, the recovering auto and industrial markets helped the company to deliver good results.

Tags: research rating hold increased

 

UPM-Kymmene Co. (UPMKY) Upgraded to Buy by Zacks Investment Research

2016-03-25 12:04:50| Paper - Topix.net

The brokerage currently has a $21.00 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 14.01% from the stock's current price.

Tags: buy research investment upgraded

 
 

Mobil'nye Telesistemy PAO (MBT) Downgraded to "Hold" at Zacks Investment Research

2016-03-25 07:32:03| Telecom - Topix.net

According to Zacks, "MOBILE TELE-ADR mission is to build a integrated mobile communications world, which will bring people together, enrich their lives and open up new horizons, both at work and at home. They will do this by Anticipating on and understanding of our customers' needs, employing experienced, qualified and highly motivated personnel, introducing new technologies, and enhancing our company's development.

Tags: research hold investment pao

 

Mobil'nye Telesistemy PAO (MBT) Downgraded to "Hold" at Zacks Investment Research

2016-03-25 07:29:28| Wireless - Topix.net

According to Zacks, "MOBILE TELE-ADR mission is to build a integrated mobile communications world, which will bring people together, enrich their lives and open up new horizons, both at work and at home. They will do this by Anticipating on and understanding of our customers' needs, employing experienced, qualified and highly motivated personnel, introducing new technologies, and enhancing our company's development.

Tags: research hold investment pao

 

Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research

2016-03-25 03:28:33| Biotech - Topix.net

According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.

Tags: research rating hold investment

 

Sites : [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] next »